Carregant...

Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia

BACKGROUND: Effective prophylactic vaccines are available against human papillomavirus (HPV) types 6, 11, 16, and 18 which are licensed for routine use among young women. Monitoring is needed to demonstrate protection against cervical cancer, to verify duration of protection, and assess replacement...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Uusküla, Anneli, Kals, Mart, Kosenkranius, Liina, McNutt, Louise-Anne, DeHovitz J, Jack
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2841185/
https://ncbi.nlm.nih.gov/pubmed/20222944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-10-63
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!